• Corpus ID: 43827963

Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.

  title={Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.},
  author={Jodi M. Gonzalez and Peter Thompson and Michael Escamilla and Mako Araga and Vivek Singh and Niamh Mehigan Farrelly and Michael E. Thase and David J. Miklowitz and Charles L. Bowden},
  journal={Psychopharmacology bulletin},
  volume={40 1},
OBJECTIVE Across ethnicity/race, prevalence rates of bipolar disorder are similar. However, African Americans and Latinos may receive less specialty mental health treatment and different medications, and may be less adherent to treatment regimens than European American patients. This study compared illness characteristics, treatment history, and overall functioning in a sample of European American, African American, and Latino patients with bipolar disorder. METHODS The samples were drawn… 

Racial/Ethnic Group Differences in Bipolar Symptomatology in a Community Sample of Persons With Bipolar I Disorder

The data show that the expression and functional impairments of bipolar I disorder is very similar across racial ethnic groups using this community-based sample, with results suggesting that provider biases are more likely to explain problems in misdiagnosis than fundamental differences in the presentation of bipolar disorder across racial/ethnic groups.

One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD.

Results are consistent with U.S. clinical trials for other psychiatric disorders, which have reported similar outcomes for ratings of primary symptoms, and are less generalizable to uninsured patients.

Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder

Investigation of differences in mood stabilizer use and mental health service utilization between adult English-speaking Hispanic and non-Hispanic white respondents with bipolar disorder found no Hispanics were receiving minimally adequate treatment for their bipolar disorder.

Disparities in Diagnosis of Bipolar Disorder in Individuals of African and European Descent: A Review

A systematic review of the existing literature on racial disparities in diagnosis and treatment of bipolar disorder found black patients have consistently been found to be more likely than white patients to be diagnosed with schizophrenia rather than bipolar disorder.

Gender and Ethnicity Group Differences Among Substance Abuse Treatment Clients Insured Under Managed Care

Significant interaction effects between gender and ethnicity were found, including findings that Caucasian women had more in common with non‐Caucasian women and men than with Caucasian men.

Inadequate treatment of black Americans with bipolar disorder.

No black respondent received minimally adequate mood-stabilizing treatment, and blacks were less likely than whites to have taken a mood stabilizer in the prior year.

Longitudinal Racial/Ethnic Disparities in Antimanic Medication Use in Bipolar-I Disorder

Objective:To examine racial/ethnic longitudinal disparities in antimanic medication use among adults with bipolar-I disorder. Methods:Observational study using administrative data from Florida's

Explaining Racial Disparity in Bipolar Disorder Treatment: How Do Providers Contribute?

This study identified and tested how treatment providers’ racial biases contribute to the inadequate care of black patients with bipolar disorder, and provided some of the first evidence establishing the presence or implicit racial biases in mental healthcare.

Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanians Study.

This study demonstrated the effectiveness of SCBD and the additional benefit of ECI independent of age, race, or place of residence and demonstrated that new mood episodes are frequent in individuals with bipolar disorder who achieve recovery and are likely to occur in spite of specialized, guideline-based treatments.

Bipolar-I patient characteristics associated with differences in antimanic medication prescribing.

Despite increasing pharmacotherapy options, there was no evidence that over time more patients received antimanic medication, and not all prescribing differences were consistent with the medical literature.